Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews
Open Access
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (4) , 752-758
Abstract
No abstract availableKeywords
Funding Information
- American Cancer Society (CA118953, CA163438)
- NCATS
- National Cancer Institute
This publication has 19 references indexed in Scilit:
- Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent UnderstandingValue in Health, 2011
- The Patient-Reported Outcome (PRO) Consortium: Filling Measurement Gaps for PRO End Points to Support Labeling ClaimsClinical Pharmacology & Therapeutics, 2011
- Have we made progress in the management of chronic graft-vs-host disease?Best Practice & Research Clinical Haematology, 2010
- Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force ReportValue in Health, 2009
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2006
- Symptoms in patients with lung carcinomaCancer, 2005
- Measuring validity of self-reported symptoms among people with HIVAIDS Care, 2004
- Chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2003
- Should symptoms be scaled for intensity, frequency, or both?Palliative and Supportive Care, 2003
- Development and validation of a scale to measure symptoms of chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2002